Results 171 to 180 of about 97,566 (303)

Species Selection Index (SSI): A novel tool designed for bio-resource selection under Access and Benefit Sharing (ABS) mechanism

Archives of Agriculture and Environmental Science, 2019
U. Joshi, S. Sharma, S. Seal, S. Khan
openaire   +1 more source

The use and exchange of biological control agents for food and agriculture [PDF]

, 2009
Barratt, I.P., Bigler, F., Bolckmans, K., Brodeur, J., Cock, M.J.W., Cônsoli, F.L., Haas, F., Lenteren, J.C., van, Mason, P.G., Parra, J.R.P.   +9 more
core   +1 more source

Morphological and morphometric aspects of the equine aortic valve: New insights for comparative studies in mammals

The Anatomical Record, EarlyView.
Abstract New data on the equine aortic valve obtained using advanced techniques is especially important given the greater availability of animal models for translational research. Here we characterized the morphological and morphometric aspects of the equine aortic valve from 60 healthy hearts collected at equine abattoirs.
Vitor Pires Pereira, Victoria Brondani de Oliveira, Carlos Eduardo Seyfert, Luciano de Morais‐Pinto   +3 more
wiley   +1 more source

Applications of artificial intelligence and the challenges in health technology assessment: a scoping review and framework with a focus on economic dimensions. [PDF]

Health Econ Rev
Ramezani M, Bakhtiari A, Daroudi R, Mobinizadeh M, Fazaeli AA, Olyaeemanesh A, Rabiee HR, Ramezani M, Mostafavi H, Sazgarnejad S, Bordbar S, Takian A.   +11 more
europepmc   +1 more source

Hiding in Plain Sight: Rethinking the Size and Complexity of Iron Age Hillforts in NW Iberia Thanks to Aerial Archaeology and Geophysics

Archaeological Prospection, EarlyView.
ABSTRACT This paper tackles one key limitation in the analysis of Iron Age communities in the Northwestern Iberian Peninsula: the limited exploration of areas beyond the fortified settlements known as castros (hillforts). The vast majority of archaeological studies have focused exclusively on the areas inside the walls of these settlements, which are ...
César Parcero‐Oubiña, Carlos Otero‐Vilariño, María Gómez‐Faro, Jesús Ignacio Jiménez Chaparro, Pastor Fábrega‐Álvarez, Juan Torrejón‐Valdelomar, Marta Crespo‐Fernández, David González‐Álvarez   +7 more
wiley   +1 more source

Private health insurance in Gulf Cooperation Council countries: A scoping review. [PDF]

Health Policy Open
Reka H, van Kessel R, Mossialos E, Groot W, Pavlova M.   +4 more
europepmc   +1 more source

A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis

Arthritis &Rheumatology, Accepted Article.
Background Individuals with serum elevations of anti‐cyclic citrullinated peptide (anti‐CCP) antibodies are at increased risk for future rheumatoid arthritis (RA). No pharmacologic interventions have been approved for the prevention of RA in such ‘at‐risk’ individuals. However, hydroxychloroquine (HCQ) is used without supporting clinical trial evidence.
Kevin D. Deane, Christopher C. Striebich, Marie L. Feser, James R. O'Dell, Judith A. James, Jeffrey A. Sparks, John M. Davis, Jonathan Graf, Maureen A. McMahon, Elizabeth B. Solow, Lindsy Forbess, Athan Tiliakos, Elena Schiopu, Maria I. Danila, Diane L. Horowitz, Jonathan Kay, Colin D. Strickland, Joel M. Guthridge, Cristina Arriens, Jennifer M. Grossman, M. Kristen Demoruelle, Elizabeth A. Bemis, Ashley Frazer‐Abel, Chelsie L. Fleischer, David A. Fox, Ted R. Mikuls, Melissa Greenleaf, Kate York, Sarah Walker, Lynette Keyes‐Elstein, Margie Byron, Janel Fedler, Ellen A. Goldmuntz, V. Michael Holers   +33 more
wiley   +1 more source

Investigating facilitators and barriers of university-based administrative staff, residents and researchers to implement an active breaks intervention: a mixed-methods study. [PDF]

BMJ Open
Pinelli E, Masini A, Scoppolini Massini M, Dallolio L, Bragonzoni L.   +4 more
europepmc   +1 more source

Ethics, Justice and the Convention on Biological Diversity [PDF]

, 2010
Pisupati, Balakrishna, Schroeder, Doris
core  

Identification of histone deacetylase inhibitor targeting type I interferon and B‐cell abnormalities in systemic lupus erythematosus

Arthritis &Rheumatology, Accepted Article.
Objective Systemic lupus erythematosus (SLE) is characterized by increased type I interferon (IFN‐I) and autoantibody production. This study aimed to identify drugs that can inhibit both IFN‐I and autoantibody production. Methods We identified an inhibitor of IFN‐I production from a chemical library.
Takehiro Hirayama, Hachiro Konaka, Yasuhiro Kato, Takayuki Shibahara, Chisato Nishizawa, Kohei Tsujimoto, JeongHoon Park, Eri Itotagawa, Tatsunori Jo, Masayuki Nishide, Sumiyuki Nishida, Yoshihito Shima, Masashi Narazaki, Wataru Aoki, Ken J Ishii, Hyota Takamatsu, Atsushi Kumanogoh   +16 more
wiley   +1 more source